Patents by Inventor SeungBaek Lee

SeungBaek Lee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200323860
    Abstract: This document provides methods and materials for treating cancer. For example, methods and materials for identifying a mammal as having cancer cells that express little, or no, Parkin mRNA or Parkin polypeptide and administering one or more mitotic kinase inhibitors to treat the mammal identified as having cancer cells with a Parkin deficiency are provided. Methods and materials for identifying a mammal as having a cancer that is responsive to treatment with one or more mitotic kinase inhibitors also are provided.
    Type: Application
    Filed: June 29, 2020
    Publication date: October 15, 2020
    Applicant: Mayo Foundation for Medical Education and Research
    Inventors: Zhenkun Lou, SeungBaek Lee, JungJin Kim
  • Patent number: 10526606
    Abstract: Materials and methods for treating cancer (e.g., by reducing metastasis) are provided herein. For example, materials and methods for treating cancer by targeting WSB1 and/or pVHL are provided.
    Type: Grant
    Filed: September 21, 2018
    Date of Patent: January 7, 2020
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Zhenkun Lou, JungJin Kim, SeungBaek Lee
  • Publication number: 20190010501
    Abstract: Materials and methods for treating cancer (e.g., by reducing metastasis) are provided herein. For example, materials and methods for treating cancer by targeting WSB1 and/or pVHL are provided.
    Type: Application
    Filed: September 21, 2018
    Publication date: January 10, 2019
    Inventors: Zhenkun Lou, JungJin Kim, SeungBaek Lee
  • Publication number: 20180344736
    Abstract: This document provides methods and materials for treating cancer. For example, methods and materials for identifying a mammal as having cancer cells that express little, or no, Parkin mRNA or Parkin polypeptide and administering one or more mitotic kinase inhibitors to treat the mammal identified as having cancer cells with a Parkin deficiency are provided. Methods and materials for identifying a mammal as having a cancer that is responsive to treatment with one or more mitotic kinase inhibitors also are provided.
    Type: Application
    Filed: September 8, 2016
    Publication date: December 6, 2018
    Applicant: Rochester
    Inventors: Zhenkun Lou, SeungBaek Lee, JungJin Kim
  • Patent number: 10093930
    Abstract: Materials and methods for treating cancer (e.g., by reducing metastasis) are provided herein. For example, materials and methods for treating cancer by targeting WSB1 and/or pVHL are provided.
    Type: Grant
    Filed: May 6, 2016
    Date of Patent: October 9, 2018
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Zhenkun Lou, JungJin Kim, SeungBaek Lee